Stephan Urwyler

3.3k total citations · 1 hit paper
55 papers, 2.8k citations indexed

About

Stephan Urwyler is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Spectroscopy. According to data from OpenAlex, Stephan Urwyler has authored 55 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Cellular and Molecular Neuroscience, 39 papers in Molecular Biology and 8 papers in Spectroscopy. Recurrent topics in Stephan Urwyler's work include Neuroscience and Neuropharmacology Research (37 papers), Receptor Mechanisms and Signaling (23 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). Stephan Urwyler is often cited by papers focused on Neuroscience and Neuropharmacology Research (37 papers), Receptor Mechanisms and Signaling (23 papers) and Neurotransmitter Receptor Influence on Behavior (14 papers). Stephan Urwyler collaborates with scholars based in Switzerland, Japan and United States. Stephan Urwyler's co-authors include Klemens Kaupmann, Johannes Mosbacher, Wolfgang Froestl, Kurt Lingenhoehl, Jakob Heid, Bernhard Bettler, D. M. Coward, Karin Hofstetter, F. Gasparini and Manuel Koller and has published in prestigious journals such as Pharmacological Reviews, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Stephan Urwyler

55 papers receiving 2.6k citations

Hit Papers

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, sel... 1999 2026 2008 2017 1999 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist
    1999 628 citations F. Gasparini, Kurt Lingenhöhl et al. Neuropharmacology profile →

Peers

Stephan Urwyler
Ram K. Mishra Canada
Juan F. López‐Giménez United Kingdom
Michael P. Johnson United States
Eddi Meier Denmark
Andrew B. Norman United States
Thomas P. Blackburn United States
Xavier Guitart Spain
Katie M. Vance United States
Milt Titeler United States
Malcolm J. Sheardown Denmark
Ram K. Mishra Canada
Stephan Urwyler
Citations per year, relative to Stephan Urwyler Stephan Urwyler (= 1×) peers Ram K. Mishra

Countries citing papers authored by Stephan Urwyler

Since Specialization
Citations

This map shows the geographic impact of Stephan Urwyler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephan Urwyler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephan Urwyler more than expected).

Fields of papers citing papers by Stephan Urwyler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephan Urwyler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephan Urwyler. The network helps show where Stephan Urwyler may publish in the future.

Co-authorship network of co-authors of Stephan Urwyler

This figure shows the co-authorship network connecting the top 25 collaborators of Stephan Urwyler. A scholar is included among the top collaborators of Stephan Urwyler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephan Urwyler. Stephan Urwyler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Orain, David, Silvio Ofner, Manuel Koller, et al.. (2011). 6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 22(2). 996–999. 16 indexed citations
2.
Koller, Manuel, Kurt Lingenhoehl, Markus Schmutz, et al.. (2011). Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity. Bioorganic & Medicinal Chemistry Letters. 21(11). 3358–3361. 33 indexed citations
3.
Nguyen, Kong T., Salahuddin Syed, Stephan Urwyler, et al.. (2009). 3-(Aminomethyl)piperazine-2,5-dione as a novel NMDA glycine site inhibitor from the chemical universe database GDB. Bioorganic & Medicinal Chemistry Letters. 19(14). 3832–3835. 19 indexed citations
4.
Nguyen, Kong T., Salahuddin Syed, Stephan Urwyler, et al.. (2008). Discovery of NMDA Glycine Site Inhibitors from the Chemical Universe Database GDB. ChemMedChem. 3(10). 1520–1524. 34 indexed citations
5.
Urwyler, Stephan, et al.. (2008). Changes in the properties of allosteric and orthosteric GABAB receptor ligands after a continuous, desensitizing agonist pretreatment. European Journal of Pharmacology. 603(1-3). 37–41. 14 indexed citations
6.
Hintermann, Samuel, Ivo Vranesic, Hans Allgeier, et al.. (2006). ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: Identification, in vitro pharmacology, pharmacokinetic and biodistribution studies. Bioorganic & Medicinal Chemistry. 15(2). 903–914. 55 indexed citations
7.
Desrayaud, Sandrine, et al.. (2006). The positive allosteric modulator GS39783 enhances GABAB receptor‐mediated inhibition of cyclic AMP formation in rat striatum in vivo. Journal of Neurochemistry. 96(5). 1416–1422. 24 indexed citations
8.
9.
Urwyler, Stephan, Mario F. Pozza, Kurt Lingenhoehl, et al.. (2003). N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and Structurally Related Compounds: Novel Allosteric Enhancers of γ-Aminobutyric AcidB Receptor Function. Journal of Pharmacology and Experimental Therapeutics. 307(1). 322–330. 153 indexed citations
10.
Urwyler, Stephan, et al.. (2003). Selected amino acids, dipeptides and arylalkylamine derivatives do not act as allosteric modulators at GABAB receptors. European Journal of Pharmacology. 483(2-3). 147–153. 21 indexed citations
11.
Gasparini, F., Valeria Bruno, Giuseppe Battaglia, et al.. (1999). (R, S)-4-Phosphonophenylglycine, a Potent and Selective Group III Metabotropic Glutamate Receptor Agonist, Is Anticonvulsive and Neuroprotective In Vivo. Journal of Pharmacology and Experimental Therapeutics. 289(3). 1678–1687. 143 indexed citations
12.
Gasparini, F., Kurt Lingenhöhl, Natacha Stoehr, et al.. (1999). 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology. 38(10). 1493–1503. 628 indexed citations breakdown →
13.
14.
Urwyler, Stephan, Elizabeth Campbell, Gert Fricker, et al.. (1996). Biphenyl-derivatives of 2-amino-7-phosphono-heptanoic acid, a novel class of potent competitive N-Methyl-D-aspartate receptor antagonists—II. Pharmacological characterization in vivo. Neuropharmacology. 35(6). 655–669. 27 indexed citations
15.
Markstein, R., Stephan Urwyler, A.L. Jaton, et al.. (1996). SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptors. Journal of Neural Transmission. 103(1-2). 17–30. 16 indexed citations
16.
17.
18.
Coward, D. M., et al.. (1989). Biochemical and behavioural properties of clozapine. Psychopharmacology. 99(S1). S6–S12. 99 indexed citations
19.
Coward, D. M., A. K. Dixon, Stephan Urwyler, & J. M. Vigouret. (1988). Pharmacological Properties of SDZ 208-912: A Potential High Potency,Non-Classical Neuroleptic. Pharmacopsychiatry. 21(6). 312–313. 9 indexed citations
20.
Urwyler, Stephan. (1987). Affinity Shifts Induced by Cations Do Not Reliably Predict the Agonistic or Antagonistic Nature of Ligands at Brain Dopamine Receptors. Journal of Neurochemistry. 49(5). 1415–1420. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ram K. Mishra Breakdown of academic impact, for papers by Juan F. López‐Giménez Breakdown of academic impact, for papers by Michael P. Johnson Breakdown of academic impact, for papers by Eddi Meier Breakdown of academic impact, for papers by Andrew B. Norman Breakdown of academic impact, for papers by Thomas P. Blackburn Breakdown of academic impact, for papers by Xavier Guitart Breakdown of academic impact, for papers by Katie M. Vance Breakdown of academic impact, for papers by Milt Titeler Breakdown of academic impact, for papers by Malcolm J. Sheardown
Rankless by CCL
2026